BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32571221)

  • 1. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening.
    Hadique S; Jain P; Hadi Y; Baig A; Parker JE
    BMC Med Imaging; 2020 Jun; 20(1):69. PubMed ID: 32571221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of
    Wong TH; Tan TH; George UR; Kow KS; Liam CK
    Med J Malaysia; 2019 Jun; 74(3):250-256. PubMed ID: 31256186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static
    Ye Q; Wu J; Lu Y; Naganawa M; Gallezot JD; Ma T; Liu Y; Tanoue L; Detterbeck F; Blasberg J; Chen MK; Casey M; Carson RE; Liu C
    Phys Med Biol; 2018 Sep; 63(17):175015. PubMed ID: 30095083
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy.
    Koslow M; Young JR; Yi ES; Baqir M; Decker PA; Johnson GB; Ryu JH
    Eur Radiol; 2019 Apr; 29(4):1684-1692. PubMed ID: 30288558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of FDG PET/CT for Preoperative Staging of Non-Small Cell Lung Cancers Manifesting as Subsolid Nodules With a Solid Portion of 3 cm or Smaller.
    Suh YJ; Park CM; Han K; Jeon SK; Kim H; Hwang EJ; Lee JH; Paeng JC; Lee CH; Kim YT; Goo JM
    AJR Am J Roentgenol; 2020 Mar; 214(3):514-523. PubMed ID: 31846374
    [No Abstract]   [Full Text] [Related]  

  • 7. Prone position [
    Lee HJ; Son HJ; Yun M; Moon JW; Kim YN; Woo JY; Lee SH
    Eur Radiol; 2021 Jul; 31(7):4606-4614. PubMed ID: 33852046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the diagnostic efficacy of
    Niyonkuru A; Chen X; Bakari KH; Wimalarathne DN; Bouhari A; Arnous MMR; Lan X
    Cancer Med; 2020 Feb; 9(3):931-942. PubMed ID: 31837121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
    Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
    BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Lung Nodule Management Algorithms for Lung-RADS Category 4 Lesions.
    Gupta S; Jacobson FL; Kong CY; Hammer MM
    Acad Radiol; 2021 Aug; 28(8):1037-1042. PubMed ID: 32540198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A feasibility study of pulmonary nodule detection by ultralow-dose CT with adaptive statistical iterative reconstruction-V technique.
    Ye K; Zhu Q; Li M; Lu Y; Yuan H
    Eur J Radiol; 2019 Oct; 119():108652. PubMed ID: 31521879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer.
    Casselden E; Sheerin F; Winter SC
    Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):243-247. PubMed ID: 30535976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
    Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
    Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does FDG-PET/CT for incidentally found pulmonary lesions lead to a cascade of more incidental findings?
    Sluijter TE; Yakar D; Roest C; Tsoumpas C; Kwee TC
    Clin Imaging; 2024 Apr; 108():110116. PubMed ID: 38460254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT.
    Mascalchi M; Mazzoni LN; Falchini M; Belli G; Picozzi G; Merlini V; Vella A; Diciotti S; Falaschi F; Lopes Pegna A; Paci E
    Br J Radiol; 2012 Aug; 85(1016):1134-9. PubMed ID: 21976631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of
    Delgado Bolton RC; Calapaquí-Terán AK; Giammarile F; Rubello D
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(4):229-233. PubMed ID: 31202725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-low-dose CT reconstructed with ASiR-V using SmartmA for pulmonary nodule detection and Lung-RADS classifications compared with low-dose CT.
    Ye K; Chen M; Li J; Zhu Q; Lu Y; Yuan H
    Clin Radiol; 2021 Feb; 76(2):156.e1-156.e8. PubMed ID: 33293025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chest radiography or chest CT plus head and neck CT versus
    Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
    Raghu VK; Zhao W; Pu J; Leader JK; Wang R; Herman J; Yuan JM; Benos PV; Wilson DO
    Thorax; 2019 Jul; 74(7):643-649. PubMed ID: 30862725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.